Literature DB >> 22143804

Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3.

Phillip M Rappold1, Mei Cui, Adrianne S Chesser, Jacqueline Tibbett, Jonathan C Grima, Lihua Duan, Namita Sen, Jonathan A Javitch, Kim Tieu.   

Abstract

The herbicide paraquat (PQ) has increasingly been reported in epidemiological studies to enhance the risk of developing Parkinson's disease (PD). Furthermore, case-control studies report that individuals with genetic variants in the dopamine transporter (DAT, SLC6A) have a higher PD risk when exposed to PQ. However, it remains a topic of debate whether PQ can enter dopamine (DA) neurons through DAT. We report here a mechanism by which PQ is transported by DAT: In its native divalent cation state, PQ(2+) is not a substrate for DAT; however, when converted to the monovalent cation PQ(+) by either a reducing agent or NADPH oxidase on microglia, it becomes a substrate for DAT and is accumulated in DA neurons, where it induces oxidative stress and cytotoxicity. Impaired DAT function in cultured cells and mutant mice significantly attenuated neurotoxicity induced by PQ(+). In addition to DAT, PQ(+) is also a substrate for the organic cation transporter 3 (Oct3, Slc22a3), which is abundantly expressed in non-DA cells in the nigrostriatal regions. In mice with Oct3 deficiency, enhanced striatal damage was detected after PQ treatment. This increased sensitivity likely results from reduced buffering capacity by non-DA cells, leading to more PQ(+) being available for uptake by DA neurons. This study provides a mechanism by which DAT and Oct3 modulate nigrostriatal damage induced by PQ(2+)/PQ(+) redox cycling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22143804      PMCID: PMC3251116          DOI: 10.1073/pnas.1115141108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.

Authors:  D C German; K F Manaye; P K Sonsalla; B A Brooks
Journal:  Ann N Y Acad Sci       Date:  1992-05-11       Impact factor: 5.691

2.  Predicting Parkinson's disease.

Authors:  S H Snyder; R J D'Amato
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

3.  A mechanism of paraquat toxicity involving nitric oxide synthase.

Authors:  B J Day; M Patel; L Calavetta; L Y Chang; J S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

Authors:  W J Nicklas; I Vyas; R E Heikkila
Journal:  Life Sci       Date:  1985-07-01       Impact factor: 5.037

5.  Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma.

Authors:  S C Lee; D W Dickson; W Liu; C F Brosnan
Journal:  J Neuroimmunol       Date:  1993-07       Impact factor: 3.478

6.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

Authors:  J W Langston; P Ballard; J W Tetrud; I Irwin
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

Review 7.  Nitric oxide and reactive oxygen species in Parkinson's disease.

Authors:  Kim Tieu; Harry Ischiropoulos; Serge Przedborski
Journal:  IUBMB Life       Date:  2003-06       Impact factor: 3.885

8.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.

Authors:  B Giros; M Jaber; S R Jones; R M Wightman; M G Caron
Journal:  Nature       Date:  1996-02-15       Impact factor: 49.962

9.  Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

Authors:  J A Javitch; R J D'Amato; S M Strittmatter; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

10.  Complement and cytokine gene expression in cultured microglial derived from postmortem human brains.

Authors:  D G Walker; S U Kim; P L McGeer
Journal:  J Neurosci Res       Date:  1995-03-01       Impact factor: 4.164

View more
  62 in total

Review 1.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

Review 2.  Targeting NOX enzymes in the central nervous system: therapeutic opportunities.

Authors:  Silvia Sorce; Karl-Heinz Krause; Vincent Jaquet
Journal:  Cell Mol Life Sci       Date:  2012-05-30       Impact factor: 9.261

Review 3.  New insights on NOX enzymes in the central nervous system.

Authors:  Zeynab Nayernia; Vincent Jaquet; Karl-Heinz Krause
Journal:  Antioxid Redox Signal       Date:  2014-01-16       Impact factor: 8.401

4.  Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.

Authors:  Fanpeng Zhao; Wenzhang Wang; Chunyu Wang; Sandra L Siedlak; Hisashi Fujioka; Beisha Tang; Xiongwei Zhu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-16       Impact factor: 5.187

Review 5.  Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.

Authors:  Arthi Kanthasamy; Huajun Jin; Adhithiya Charli; Anantharam Vellareddy; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

Review 6.  What does genetics tell us about imprinting and the placenta connection?

Authors:  Susannah Varmuza; Kamelia Miri
Journal:  Cell Mol Life Sci       Date:  2014-09-07       Impact factor: 9.261

7.  Role of OCT2 and MATE1 in renal disposition and toxicity of nitidine chloride.

Authors:  L P Li; F F Song; Y Y Weng; X Yang; K Wang; H M Lei; J Ma; H Zhou; H D Jiang
Journal:  Br J Pharmacol       Date:  2016-07-09       Impact factor: 8.739

8.  Microstructural changes in the substantia nigra of asymptomatic agricultural workers.

Authors:  Guangwei Du; Mechelle M Lewis; Nicholas W Sterling; Lan Kong; Honglei Chen; Richard B Mailman; Xuemei Huang
Journal:  Neurotoxicol Teratol       Date:  2013-12-12       Impact factor: 3.763

Review 9.  Catecholamine/Serotonin interactions: systems thinking for brain function and disease.

Authors:  Julie G Hensler; Francesc Artigas; Analía Bortolozzi; Lynette C Daws; Philippe De Deurwaerdère; Léa Milan; Sylvia Navailles; Wouter Koek
Journal:  Adv Pharmacol       Date:  2013

10.  Glutathione deficiency in Gclm null mice results in complex I inhibition and dopamine depletion following paraquat administration.

Authors:  Li-Ping Liang; Terrance J Kavanagh; Manisha Patel
Journal:  Toxicol Sci       Date:  2013-05-23       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.